Save time and get answers to complex questions with AI chat
Pramlintide approval date?Complera manufacturer?Motegrity ingredients?Patent expiry trametinib?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for ingrezza
Ingrezza (valbenazine) is used to treat tardive dyskinesia, a movement disorder that causes involuntary, repetitive movements such as lip smacking, tongue movements, or facial grimacing. [1]
Clinicians prescribe Ingrezza for people who have tardive dyskinesia, which is most often associated with long-term use of certain antipsychotic medicines. [1]
Based on the information available here, Ingrezza is specifically indicated for tardive dyskinesia. [1]
[1] https://www.drugs.com/ingrezza.html
Other Questions About Ingrezza :